KaloCyte, Inc.
PrivateLast Round
Seed
Feb 24, 2025
Total Funding Raised
$21.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
KaloCyte, Inc. operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Grant round in February 2025.
KaloCyte, Inc. is a biotechnology company developing ErythroMer™, a dried, bio-inspired artificial red blood cell substitute for use when stored red blood cells are unavailable.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KaloCyte, Inc. Comparables
Compare KaloCyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 85% | |
| NanoBlood LLC | 85% | |
| Fluoro2 Therapeutics | 82% |
For institutional investors. Book with your work email.
KaloCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 24, 2025 | ||||
| Grant | Feb 1, 2025 | ||||
| Grant | Jan 28, 2025 | ||||
| Grant | Apr 15, 2024 | ||||
| Grant | Aug 22, 2023 | ||||
Debt | Jul 17, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
KaloCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Debt |
| BioGenerator Ventures | Angel |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Old Line Capital Partners | Convertible Debt |
| Ferocity Capital | Seed |
| Congressionally Directed Medical Research Programs | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 30% MoM, reaching 4.2K.
- Aug 21, 2026
Monthly visitors increased 114% MoM.
For institutional investors. Book with your work email.
KaloCyte, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KaloCyte, Inc.'s valuation, stock price, and market status.
Is KaloCyte, Inc. a public or private company?
KaloCyte, Inc. is a private company.
What is the current stock price of KaloCyte, Inc.?
KaloCyte, Inc. is a private company, so its shares have no public market price. Caplight tracks KaloCyte, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KaloCyte, Inc. worth (valuation)?
Valuation information for KaloCyte, Inc. is not publicly available.
Can I buy KaloCyte, Inc. stock?
KaloCyte, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KaloCyte, Inc.'s last funding round?
KaloCyte, Inc.'s most recent funding round was Seed on February 24, 2025.
Who are the main investors in KaloCyte, Inc.?
Key investors in KaloCyte, Inc. include Ferocity Capital.
Will KaloCyte, Inc. IPO soon?
No public IPO plans have been announced for KaloCyte, Inc..
How can I track KaloCyte, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in KaloCyte, Inc.'s shares on secondary markets.